REGULATED CRYPTO EXCHANGE
Русский
Español
Neurocrine
Sell105.48
Spread0.33
Buy105.81

Trade Neurocrine Biosciences, Inc. - NBIX stock price

Sell105.48
Spread0.33
Buy105.81
1m
5m
15m
30m
1H
4H
1D
1W
History
Open on platform
Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's lead products include INGREZZA (valbenazine), a vesicular monoamine transporter 2 inhibitor (VMAT2), which is used for the treatment of movement disorders; elagolix, a gonadotropin-releasing hormone (GnRH) antagonist that is in Phase III clinical trial for use in women's health; and opicapone, a catechol-O-methyltransferase inhibitor, which is in Phase III clinical trial that is used for in adjunct therapy and preparations of levodopa/DOPA decarboxylase inhibitors for adult patients with Parkinson's disease. It is also developing NBI-74788, which is in Phase II clinical trial that is used for the treatment of congenital adrenal hyperplasia. In addition, the company's research programs comprise VMAT2 Inhibitors for movement disorders, bipolar disorders, and schizophrenia; and G Protein-Coupled Receptors and Ion Channels for epilepsy, essential tremor, pain, dystonia, and other indications. It has collaborations and agreements with AbbVie Inc. to develop and commercialize elagolix and GnRH antagonists for women's and men's health; Mitsubishi Tanabe Pharma Corporation to develop and commercialize INGREZZA for movement disorders; and BIAL Portela & Ca, S.A. to develop and commercialize opicapone for the treatment of human diseases and conditions, including Parkinson's disease. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.
White Paper Declaration

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Download on the App Store Get it on Google Play Explore platform Show QR
Articles
Bitcoin ETF approvals spark mass BTC adoption, experts say
Read more
QCP Capital explains when to expect Bitcoin’s all-time high
Read more
Aussie crypto exchange seeks to reclaim $328k after major fat-finger crediting mistake
Read more
Bitcoin whales invest $700b as BTC price heads to $70k
Read more
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

NBIX price history

  • Last 7 days
  • Last 30 days
  • Last Year
  • Last 2 Years
  • Maximum Period
  • Daily
  • Weekly
  • Monthly
Date Close Change Chg% Open Min. Max.
2022-09-30 105.48 -0.80 -0.75 106.28 105.36 108.18
2022-09-30 106.96 -0.75 -0.70 107.71 105.06 107.73
2022-09-30 107.7 2.37 2.25 105.33 104.63 108.37
2022-09-30 105.96 -0.74 -0.69 106.7 104.5 107.12
2022-09-30 106.77 3.82 3.71 102.95 102.95 106.9
2022-09-30 104.13 1.54 1.50 102.59 100.25 104.28
2022-09-30 102.59 -3.13 -2.96 105.72 102.53 105.78
2022-09-30 106.51 0.28 0.26 106.23 103.33 106.8
2022-09-30 106.31 -0.57 -0.53 106.88 105.87 107.37
2022-09-30 106.5 1.47 1.40 105.03 104.46 108.05
2022-09-30 105.38 2.47 2.40 102.91 102.02 105.82
2022-09-30 102.87 -0.01 -0.01 102.88 101.54 103.47
2022-09-30 102.81 -2.49 -2.36 105.3 102.59 105.87
2022-09-30 105.46 2.35 2.28 103.11 101.79 105.55
2022-09-30 104.48 1.36 1.32 103.12 103.12 105.55
2022-09-30 103.12 -0.93 -0.89 104.05 102.1 104.57
2022-09-30 105.18 1.33 1.28 103.85 103.85 106.31
2022-09-30 104.74 3.03 2.98 101.71 101.71 105.63
2022-09-30 104.17 -1.89 -1.78 106.06 103.6 106.99
2022-09-30 106.32 1.79 1.71 104.53 104.52 107.71
Go help.dzengi.com